Aurobindo Pharma to Launch Biosimilars in Europe

Aurobindo Pharma, based in Hyderabad, India, is preparing to sell copies of complex medicines called biosimilars in Europe.

They have received the necessary permissions from European regulators and have begun manufacturing.

Initially, they will focus on making enough medicine for the launch.

In some areas, they will sell directly, while in others, they will work with partners.

They expect a small amount of money from sales later this year as they build up their supply.

They have approvals for four products, ready to be sold.